Esperion Therapeutics
ESPR
#6751
Rank
C$0.66 B
Marketcap
$3.39
Share price
-3.57%
Change (1 day)
158.73%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of June 2024 : -C$0.49 Billion

According to Esperion Therapeutics's latest financial reports the company has -C$0.49 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-C$0.61 Billion37.36%
2022-12-31$-C$0.44 Billion75.04%
2021-12-31$-C$0.26 Billion104.76%
2020-12-31$-C$0.13 Billion-570.44%
2019-12-31$C$26.05 M-75.82%
2018-12-31$C$0.10 B-64.97%
2017-12-31$C$0.30 B0.14%
2016-12-31$C$0.30 B-22.91%
2015-12-31$C$0.39 B157.11%
2014-12-31$C$0.15 B96.51%
2013-12-31$C$78.86 M-556.1%
2012-12-31$-C$17.3 Million180.67%
2011-12-31$-C$6.17 Million
2002-12-31$C$61.19 M-42.24%
2001-12-31$C$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.60 B-225.62%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.55 B-1,672.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$129.18 B-26,989.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$40.93 B-8,619.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.24 B-151.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.33 B-169.72%๐Ÿ‡บ๐Ÿ‡ธ USA